A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead

As a unique population of tumor bulk, cancer stem cells have been implicated in tumor relapse and chemoresistance in triple-negative breast cancer (TNBC). Therefore, understanding the phenotype of cancer stem cells can pave the way for introducing novel molecular targeted therapies for treating TNBC...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Mahdi Abdoli Shadbad, Negar Hosseinkhani, Zahra Asadzadeh, Afshin Derakhshani, Noora Karim Ahangar, Nima Hemmat, Parisa Lotfinejad, Oronzo Brunetti, Nicola Silvestris, Behzad Baradaran
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2021-08-01
Schriftenreihe:	Frontiers in Oncology
Schlagworte:	triple-negative breast cancer cancer stem cell cancer therapeutic resistance CD44 CD44/CD24 prognosis
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fonc.2021.689839/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!